Rockefeller Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Rockefeller Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1M	Hold	173,438	–	–	0.02%	693
2026 Q1	$8.35M	Hold	173,438	–	–	0.01%	739
2025 Q4	$7.15M	Hold	173,438	–	–	0.01%	769
2025 Q3	$6.73M	Buy	+173,438	New	+$5.63M	0.01%	743
2023 Q1	–	Sell	-5,750	Closed	-$86K	–	3009
2022 Q4	$86K	Hold	5,750	–	–	﹤0.01%	2102
2022 Q3	$73K	Hold	5,750	–	–	﹤0.01%	2162
2022 Q2	$55K	Hold	5,750	–	–	﹤0.01%	2233
2022 Q1	$57K	Hold	5,750	–	–	﹤0.01%	2239
2021 Q4	$67K	Buy	5,750 +5,000	+667%	+$61.4K	﹤0.01%	2087
2021 Q3	$8K	Hold	750	–	–	﹤0.01%	2995
2021 Q2	$10K	Hold	750	–	–	﹤0.01%	2776
2021 Q1	$13K	Hold	750	–	–	﹤0.01%	2481
2020 Q4	$13K	Hold	750	–	–	﹤0.01%	2154
2020 Q3	$11K	Hold	750	–	–	﹤0.01%	1987
2020 Q2	$19K	Buy	+750	New	+$15.7K	﹤0.01%	1694

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Rockefeller Capital Management's KNSA Position: Q2 2026 in Review

Rockefeller Capital Management held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 173,438 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #693.

Rockefeller Capital Management first reported a position in KNSA in Q2 2020 and has held it in 15 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Rockefeller Capital Management held 173,438 shares of Kiniksa Pharmaceuticals worth $11.1M as of Q2 2026.
Rockefeller Capital Management left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
Kiniksa Pharmaceuticals made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #693 holding.
Rockefeller Capital Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.